FindMyKOL
Clinical trialNCT04514224CompletedObservational

Gabby Implementation: Parent Protocol

NCT04514224 is an observational study sponsored by Boston Medical Center. As of 18 Nov 2026, it is completed. It studies Preconception Care. The registry lists an enrollment of 125 participants at 1 site in 1 country. The registry lists a start date of 15 Oct 2017 and a primary completion date of 15 Mar 2022.

SponsorBoston Medical Center →Enrollment125Preconception Care
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04514224
FieldValue
Registry IDNCT04514224
StatusCompleted
Study typeObservational study
Lead sponsorBoston Medical Center
Enrollment125
Registered sites1
Countries1
ConditionsPreconception Care
Start15 Oct 2017
Primary completion15 Mar 2022
Study completion15 Mar 2022
Last update posted8 Aug 2022

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Gabby Preconception Care program is an innovative communication system designed to identify and mitigate or resolve health risks for young Black and African American (AA) women before pregnancy, as a means of reducing racial health disparities in birth outcomes. The system uses embodied conversational agent technology the investigators call "Gabby," who empathically interacts with users to assess health risks and delivers interventions to resolve or mitigate these risks. This research team has been working on the "Gabby" Preconception Care program, which features Virtual Patient Advocate (VPA) technology, for over seven years and the system is now ready for dissemination beyond the research environment and into the clinical and community context. The purpose of this project is to examine the implementation and dissemination process of the evidence-based Gabby Program. Caseworkers at Healthy Start (HS) Programs and healthcare providers at Community Health Centers (CHC's) do not have time to assess for the over 100 preconception health risks that can impact birth outcomes; our system can assist by streamlining that assessment to create a personalized list of risks.Gabby will be introduced/released to sites as part of their standard of care where patients and clients can then share their list with healthcare providers and case workers/managers to make their in-person interactions much more effective. Studies by the research team have shown that Gabby reduces health risks by 25 percent among young Black and AA women. The investigators will evaluate the success of the implementation process through both quantitative and qualitative measures including key informant telephone interviews and guidance from a Gabby Toolkit Advisory Board in order to prepare an implementation toolkit that can be used to facilitate broader dissemination. The Gabby program will not be evaluated as a research intervention, as this has been done previously, instead, how well the Gabby program worked within each site will be assessed.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Massachusetts, United States1 site
  • Boston Medical Center

    Boston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04514224

Each answer restates registry values shown on this page.

What is NCT04514224?

NCT04514224 is an observational study sponsored by Boston Medical Center. It studies Preconception Care.

Who leads NCT04514224?

The registry names Brian Jack, MD (principal investigator, Boston Medical Center, Family Medicine) as the overall official.

Where does NCT04514224 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04514224 end?

The registry lists a primary completion date of 15 Mar 2022 and a study completion date of 15 Mar 2022. The sponsor last updated the record on 8 Aug 2022.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.